Other specified inflammatory spondylopathies, thoracolumbar region
ICD-10 M46.85 is a billable code used to indicate a diagnosis of other specified inflammatory spondylopathies, thoracolumbar region.
M46.85 refers to inflammatory spondylopathies that are not classified elsewhere but specifically affect the thoracolumbar region of the spine. This condition encompasses a variety of inflammatory disorders that can lead to pain, stiffness, and potential structural changes in the spine. Inflammatory spondylopathies include conditions such as ankylosing spondylitis, which is characterized by chronic inflammation of the spine and sacroiliac joints, leading to pain and eventual fusion of the vertebrae. Other inflammatory conditions may include reactive arthritis and psoriatic arthritis affecting the spine. The thoracolumbar region is particularly significant as it connects the thoracic and lumbar spine, and inflammation here can severely impact mobility and quality of life. Diagnosis typically involves clinical evaluation, imaging studies, and laboratory tests to identify inflammatory markers. Treatment may include anti-inflammatory medications, physical therapy, and in some cases, surgical intervention. Accurate coding is essential for proper management and reimbursement.
Detailed patient history, physical examination findings, imaging results, and laboratory tests indicating inflammation.
Patients presenting with chronic back pain, stiffness, and positive inflammatory markers.
Ensure that all inflammatory conditions are documented to avoid misclassification.
Surgical notes, imaging studies, and pre- and post-operative assessments.
Patients requiring surgical intervention for severe spinal stenosis or deformity due to inflammatory spondylopathy.
Document the impact of inflammation on spinal structure and function.
Used to evaluate inflammatory changes in the thoracolumbar region.
MRI reports and clinical notes indicating the need for imaging.
Rheumatologists and orthopedic surgeons should ensure imaging correlates with clinical findings.
M46.85 is used for other specified inflammatory spondylopathies affecting the thoracolumbar region, while M45 specifically refers to ankylosing spondylitis, a well-defined condition.
